W e would like to congratulate Dr.
Stein and his coauthors on the results they have demonstrated from a large number of patients with early esophageal carcinoma. 1 The conclusion of this work, that patients with pT1 squamous cell carcinoma (SCC) of the esophagus have worse prognoses than similar patients with pT1 adenocarcinoma (AC), corroborates the findings of other authors. However, the justification set forward by the authors for the difference in prognosis, that SCC metastasizes into the regional lymph nodes (LN) earlier than AC, cannot be derived from data presented in the study.
When the data from this study are analyzed, the following points indicate that the basis of the divergent prognostic courses of AC and SCC is multifactorial and not due to earlier LN metastasis of SCC:
1. The authors state that the 30-day mortality rates do not vary significantly between the 2 histologic types. However, when considering the 2 survival curves of patients with SCC and AC, despite the fact that these depictions do not contain enough data for an interpretation, 2 marked differences in hospital mortality rates (corresponding to 90-day mortality rates) are easily identified. The 90-day mortality rate is approximately 2% for patients with AC and approximately 9% for those with SCC. This distinction could be secondary to the higher preoperative risks of patients with SCC compared with those with AC. 3 Additionally, the more extensive intervention required for patients with SCC compared with that for patients with AC could also be the basis of higher postoperative mortality rates. 2. Almost double the number of AC patients had mucosal-limited carci-noma as SCC patients (36.5% vs. 18.7%). Mucosal-limited carcinoma very seldom leads to LN metastasis, regardless of histologic type. A higher rate of pN1 cases then follows a higher rate of submucosal-invading carcinomas in the pT1 SCC group compared with the pT1 AC group.
Since LN metastasis is one of the most crucial factors affecting prognosis, it is inevitable that the prognosis of these more advanced pT1 SCC patients is worse than that for AC patients. 3 . Recent studies that subclassify submucosal-invading carcinomas into thirds based on depth of penetration show a gradual increase in LN metastases occurring from sm1 through sm3 tumors. 4, 5 When stage-adjusted comparisons are made for submucosal subclassification, the rate of LN metastasis is not significantly different between AC and SCC. 5 Increased proportions of sm3 carcinomas in SCCs compared with ACs may also play a role. These have been demonstrated with comparison of submucosal-invading carcinomas in these authors' patient cohorts, and were not investigated in the Stein et al study patients. 1 
The prognostic distinction could also
be conditional on the different magnitudes of lymphadenectomy performed for the differing histologic types of disease. The more extensive lymphadenectomy associated with transthoracic esophagectomy (performed more often for cases of SCC) identifies more cases of LN metastasis than that of the transhiatal approach more often used in cases of AC. 5. Causes of death for the 2 patient groups were not mentioned. The SCC group, however, had more secondary carcinoma than the AC group. The prognosis could be worse due to these secondary tumors.
In summary, it appears that the poorer prognoses of the pT1 SCC patients compared with the pT1 AC patients presented by Stein lined esophagus (CLE) and that this finding correlated with increased esophageal acid exposure as assessed by pH monitoring. 1 CLE results from columnar metaplasia where the squamous epithelium of the esophagus is replaced by columnar type epithelium. 3 There is strong evidence that CLE is a morphologic consequence of gastroesophageal reflux disease. 1, 4, 5 In addition, low-to high-grade dysplasia and esophageal adenocarcinoma may develop within intestinal metaplasia. Very recent data coming from a histopathologic study by Chandrasoma et al 3 suggest that alteration of the geometry of the lower esophageal sphincter (LES) may contribute to the development of CLE.
Investigating the esophagogastric junction in 10 esophagectomy specimens, Chandrasoma et al 3 found that submucosal glands are present in the tubular esophagus and the proximal parts of the rugal folds (the endoscopic start of the stomach), which in turn were covered by cardiac mucosa (Ϯintestinal metaplasia) and oxyntocardiac mucosa, epithelia found within CLE. 1, 3, 5 The distance of cardiac and oxyntocardiac mucosa from the end of the tubular esophagus until oxyntic mucosa ranged from 0.31 to 2.05 cm. Based on the finding that submucosal glands were not present under gastric oxyntic mucosa, these fascinating data indicate that the proximal part of the rugal folds distal to the tubular esophagus may represent a pouchlike segment of esophagus of variable length covered by CLE. This, in turn, implicates that the esophagogastric border cannot be assessed by endoscopy; it can only be assessed by histology. As a consequence, the so-called "cardia" may represent reflux damaged, dilated pouchlike distal esophagus covered by CLE. Could pouch-like transformation of the distal esophagus result from "shortening" of the lower esophageal sphincter? This, in turn, could induce exposure of the "unprotected" distal esophagus to acid and bile and promote development of CLE.
Following esophagomyotomy (including the LES) partial anterior fundoplication (Dor) was conducted for creation of a "high pressure junctional canal" 6 between the esophagus and the stomach (ie, neo-LES). 1, 6 Since neo-LES pressure remained at stable values (7-9 mm Hg) and esophageal motility did not change (ie, remained impaired) throughout follow-up in the Csendes et al study, 1 it remains to be answered whether the presence of CLE was associated with shortening of the neo-LES antireflux barrier. In their paper, Csendes et al 1 did not show if presence of CLE and intestinal metaplasia correlated with changes of neo-LES-length during follow-up.
Therefore, the authors are kindly asked to address this issue and indicate if the presence of CLE and intestinal metaplasia was associated with a decrease of neo-LES length during followup. This in turn would profoundly aid to elicit the pathophysiology underlying the development of CLE. Bosher and Taylor in 1951 described a patient with a high stricture of the esophagus. 1 When the lesion was resected, it was found that the ulcer and stricture were located at the squamous epithelium of the esophagus and that the tube connecting this area with the stom-ach had the appearance from outside of a normal esophagus but was lined with gastric mucosa with oxyntic cells. In addition, esophageal mucosal glands were present in the submucosa, confirming that this intrathoracic segment distal to the stricture was esophagus and not stomach. 1 Later, Allison and Johnstone in 1953 described 7 patients with high strictures and the distal esophagus lined with gastric mucosa, also presenting mucosal glands in the submucosa. 2 Therefore, the theory of Barrett of a "short esophagus" was not true, and all these patients corresponded to what we know now as a longsegment Barrett esophagus.
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Therefore, the findings of Chandrasoma et al 3 "rediscover" these findings nearly 50 years later. This has been our argument for years in that we do not believe in a "short esophagus" because this distal esophageal segment covered by specialized epithelium resembles, during surgery, the "ascended stomach" corresponding to a dilated distal esophagus.
This finding was based on our studies published in 1971, 4 when we performed simultaneous manometric and radiologic studies in patients with high stricture of the esophagus, demonstrating that the tubular segment distal to the stricture had peristaltic contractions after swallowing; therefore, it was a tubular esophagus and not an ascended intrathoracic stomach.
We proposed therefore the term of "gastrification of the distal esophagus" to explain these findings, 5 a term that was also used by Chandrasoma et al many years later. 3 This terminology attempts to explain why surgeons during an operation may believe that the dilated tubular intrathoracic segment looks like an ascended stomach, due to its dilatation, its external appearance, and, internally, the gastric mucosa. However, the division of vagus nerves is at the usual location, the irrigation through the left gastric artery is located in the usual place, and mucosal glands are present in the submucosa as described previously in 1951 and 1953 and by Chandrasoma.
As Lenglinger et al, point out, patients with chronic reflux have a dilated distal pouch. The cardia has been arbitrarily located in the junction of the longitudinal esophageal muscular fibers and the gastric serosal. Above the cardia lies the "bell-shaped" structure called gastroesophageal vestibule. If the cardia is dilated, the gastroesophageal vestibule is dilated also and appears like a dilated pouch at contrasted x-ray examination. The findings of this dilatation of the cardia was measured by us in 2 different studies, 6, 7 demonstrating that the perimeter of the esophagogastric junction was significantly greater in patients with reflux esophagitis or Barrett esophagus compared with controls. In the same study, 6 patients with achalasia, who have a very tight hypertensive lower esophageal sphincter, have a reduced perimeter of the cardia, contrary to the dilatation seen in patients with gastroesophageal reflux.
The pouch-like transformation is not a cause of a "shortening of the lower esophageal sphincter." In 1993, we carefully evaluated 109 control subjects and 776 patients with different degrees of reflux esophagitis 8 demonstrating 2 findings:
1. In normal subjects, the squamocolumnar junction is located almost exactly at the mid-portion of the lower esophageal sphincter, which means that near 15 mm of the final portion of the esophagus is covered by gastric mucosa. The type of mucosa in our normal control subjects in more than 60% of the cases corresponded only to oxyntic mucosa, without cardiac mucosa. 9,10 2. According to the severity of reflux, the squamocolumnar junction ascends proximally, but the location of the lower esophageal sphincter is nearly normal. Therefore, we again postulate the total length of the esophagus does not "shorten" more than 1 or 2 cm compared with controls. 11 But they never shorten 4 or 6 or more cm.
The total length of the lower esophageal sphincter measured by manometry shows a decrease in patients with long-segment Barrett's esophagus compared with controls. However, we believe that this is only a "functional" shortening due to the presence of this pouch-like transformation of the distal esophagus; therefore, the measurements are imprecise because the manometric sensors are not able to measure the sphincter pressure properly in this pouch like the dilated gastroesophageal junction.
In the present study concerning the late control of patients with achala-sia, we have performed several manometric studies after surgery (a total of 154 studies in 64 patients after operation) and the total length (which was not reported in the paper) remained constant over time, in values between 35 and 38 mm of length. Therefore, we have not seen in any patients a shortening of the lower esophageal sphincter, even in the presence of intestinal metaplasia developing at the distal esophagus.
We again thank Lenglinger et al for their interest and their discussion in this topic. We would appreciate greatly if other surgical teams could perform such long-term follow-up studies, performing several objective evaluations in their patients and not only by performing a clinical questionnaire, but also many times only by a telephone call.
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Impact on Operating Room Efficiency of Reducing Turnover Times and Anesthesia-Controlled Times
To the Editor:
F riedman et al 1 report on the benefit of reducing turnover time (TT) and anesthesia-controlled times (ACT) on the efficiency of use of operating room (OR) time, for a single surgeon performing inguinal hernia repairs. We believe this to be a superb study taking advantage of an excellent opportunity to describe results that can be repeated elsewhere by others. The use of parallel processing has great potential to increase both the efficiency of use of OR time and contribution margin per OR hour. However, being a management case study with a single combination of surgeon and surgical suite, the n ϭ 1. Understanding how to extrapolate results to other settings requires precise understanding of the reasons why an increase in OR efficiency was achieved. The authors 1 suggest that their findings differ from those of Dexter et al 2 because the latter study was ". . . working based on the standard linear structure of patient flow through the operating day." As our paper 2 did not make that assumption, the differences reflect other factors.
First, Dexter et al 2 considered a single OR with fixed hours, 3 in which a case would be cancelled if it could not start sufficiently early to be expected to be completed on time. 4 In contrast, Friedman et al performed the cases scheduled each day. The implication is that, to gain benefit from reductions in TT and ACT, there should not be the requirement that the time reductions be achieved every time to perform a case. 4 
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Annals of Surgery • Volume 245, Number 2, February 2007 Second, by studying brief cases of the same procedure(s) performed by a single surgeon, Friedman et al 1 had small standard deviations of surgical times. The observed mean reduction in TT and ACT times was 15.8 minutes, larger than the 9.5 minutes standard deviation of surgical times. Consequently, small numbers of cases needed to be performed each day for there to be a detectable benefit, as shown by Dexter et al. 2, 5 The benefits of reducing TT and ACT are large when these times are long relative to the standard deviation of surgeon-controlled times. 2 The implication is that efforts should focus attention on procedures with predictable surgical times.
Third, whereas Dexter et al considered individual days, 2 Friedman et al 1 considered a surgeon's workload over more than 1 day. Suppose that the choice of the day on which each case was performed had not been changed by the studied surgeon as a result of the reduction in TT and ACT. Then, Friedman et al would have shown a reduction in TT and ACT, as before, but instead of an increase in OR efficiency, there would have been simply an increase in underutilized OR time. 4 -6 Only by the surgeon's choice of changing the days on which cases were scheduled were the reductions in TT and ASC effective at increasing the efficiency of use of OR time. 5 Had the Thursday afternoon allocated time described in Friedman et al 1 not been given way, OR efficiency would have been unchanged. [4] [5] [6] Very large increases in OR efficiency can be achieved by reducing TT and ACT provided staffing and case scheduling are changed simultaneously. 4 -6 Franklin Dexter, MD, PhD T he recently published article by Rossi et al 1 adds further provocative evidence to the efficacy of antireflux surgery in substantially modifying the natural history of Barrett's epithelium (BE). 2, 3 This very interesting study focuses on the most controversial field of the BE story: the biologic outcome and clinical management of BE-related precancerous lesions.
First, we would like to briefly address a nonsemantic problem of definition. In 2000, the WHO International Agency changed the term "dysplasia" to intraepithelial or noninvasive neoplasia (NiN), considering both newly proposed definitions more appropriate in identifying a biologically neoplastic lesion in its early preinvasive stage (ie, confined within the epithelial structures). 4 Consistency with the WHO Agency recommendations would result in a less controversial identification of this spectrum of genotypic/phenotypic alterations, which still represents a major (frequently unaccomplished) priority in scientific communication.
As for the results of the Rossi et al study, 1 by applying a strict follow-up protocol in BE patients treated by medical or surgical therapy, the authors documented a complete regression of lowgrade (LG) NiN in 27 of the original 35 patients enrolled with short or long BE segments (SSBE ϭ 20; LSBE ϭ 15). Based on the higher prevalence of LG-NiN regression documented in the surgically treated group (94% vs. 63% after medical treatment), the authors corroborate antireflux surgery over the medical option. Interestingly, prevalence of LG-NiN regression was not affected by length of BE, but it is of some relevance that 10 of the 15 cases of LG-NiN occurring in LSBE were assigned to medical treatment (which was associated with a less favorable outcome): in our experience at least, outcome differed significantly in SSBE and LSBE treated with antireflux surgery.
Applying a combined panel of morphologic tests (routine hematoxylin and eosin histology, HID stain for mucins, and immunocytochemistry for Cdx2 homeodomain protein), we conducted 5 a longitudinal study involving 35 BE patients treated surgically and followed up according to the same Seattle protocol, as was used by Rossi et al. 1 In our study, BE regression after surgery (ie, disappearance of IM in 17% of patients) was only observed in cases of SSBE, while follow-up biopsy documented BE regression in none of the 21 LSBE patients. It is worth noting that the median clinical/endoscopic follow-up time of our study (28 months; range, 12-99 months) was comparable with the one reported by Rossi et al. 1 If we assume that the reversibility of a metaplastic transformation is more plausible than the regression of a neoplastic (albeit noninvasive) disease, the results obtained by Rossi and by ourselves are difficult to reconcile. Such a divergence (reflected in the current literature) suggests some caution in adopting the Rossi et al follow-up schedule (based on their excellent rate of LG-NiN regression) in clinical practice. The proposal of offering a (twice-confirmed) regressed LG-NiN a 5-year endoscopy surveillance seems only partially validated by available data, and our prudential position is strongly supported by the following well-established considerations:
1. The presence of LG-NiN coincides with a 3.5-fold increase in the risk of developing HG-NiN or adenocarcinoma compared with IM alone (annualized risk 1.28% per year vs. 0.36% per year, P Ͻ 0.01). 6 2. NiN (be it LG or HG) is a patchy lesion: even adopting the Seattle protocol only a minimal amount of epithelium is sampled and the risk of missing small foci of NiN should be always considered.
3.
LG-NiN has a variable fate, sometimes "spontaneously" regressing (real regression or sampling-related disappearance?) and reappearing later on.
We are still far from a full understanding of the biology of BE, and the follow-up protocol recommended by the American College of Gastroenterology 7 remains the most suitable for a safe management of our patients and the priority of obtaining further biologic information on which to base any secondary prevention of Barrett's adenocarcinoma with confidence. patients with T1 carcinoma of the rectum were treated by either transanal excision (n ϭ 151) or radical resection (n ϭ 168) over a 17-year period. These groups were compared regarding their local recurrence and survival rate.
The long-term results showed a significantly higher local recurrence rate (15% vs. 3%) and overall recurrence rate (23% vs. 6%) for the local excision group. These findings emphasize very impressively that local excision of T1 rectal cancer is only justified if the "low risk" criteria low to moderate differentiation (G1, G2), no lymphatic invasion (L0), and tumor localization in the upper and middle part of the rectum are taken into account. 2 Deep submucosal infiltration (sm3) seems to be an additional "high risk" factor for developing local recurrence that could be demonstrated in 40 patients with T1 "low risk" rectal cancer. 3 In the series by Bentrem et al, 1 even patients with "high risk" features in the specimen after local excision did 
